Skip to main content

Table 1 Baseline characteristics of study patients according to BMI

From: Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma

Characteristic All cases Normal weight (BMI <23 kg/m2) Overweight (BMI ≥23 kg/m2) p value
No. of patients 379 (100 %) 216 (57.0 %) 163 (43.0 %)  
Age, years 63.4 ± 11.7 64.0 ± 11.5 62.6 ± 11.8 0.199
Gender, male 219 (57.6 %) 116 (53.0 %) 103 (47.0 %) 0.064
Diabetes 71 (18.7 %) 35 (49.3 %) 36 (50.7 %) 0.147
Alcohol 95 (25.1 %) 54 (56.8 %) 41 (43.2 %) 0.973
Smoking 120 (31.7 %) 74 (61.7 %) 46 (38.3 %) 0.211
AFP ≥400 μg/L 228 (60.2 %) 71 (31.1 %) 157 (68.9 %) 0.760
Viral status     0.691
 HBV 237 (62.5 %) 134 (56.5 %) 103 (43.5 %)  
 HCV 125 (33.0 %) 70 (56 %) 55 (44 %)  
 HBV + HCV 1 (0.3 %) 1 (100 %) 0 (0 %)  
 None 16 (4.2 %) 11 (68.8 %) 5 (31.2 %)  
Previous treatment     0.717
 Yes 113 (31.1 %) 66 (58.4 %) 47 (41.6 %)  
 No 250 (68.9 %) 139 (55.6 %) 111 (44.4 %)  
Child–Pugh class     2.7 × 10−4
 A 99 (26.1 %) 44 (44.4 %) 55 (55.6 %)  
 B 107 (28.2 %) 57 (53.3 %) 50 (46.7 %)  
 C 173 (45.6 %) 115 (66.5 %) 58 (33.5 %)  
Extrahepatic metastasis     0.113
 Yes 36 (9.5 %) 25 (69.4 %) 11 (30.6 %)  
 No 343 (90.5 %) 191 (55.7 %) 152 (44.3 %)  
Infiltration of portal vein     0.304
 Yes 139 (36.7 %) 84 (60.4 %) 55 (39.6 %)  
 No 240 (63.3 %) 132 (55.0 %) 108 (45.0 %)  
Treatment after diagnosis     1.3 × 10−4
 Yes 151 (39.8 %) 68 (45.0 %) 83 (55.0 %)  
 No 228 (60.2 %) 148 (64.9 %) 80 (35.1 %)  
BCLC stage     8.2 × 10−5
 0 stage 10 (2.6 %) 3 (30.0 %) 7 (70.0 %)  
 1 stage 64 (16.9 %) 28 (43.8 %) 36 (56.2 %)  
 2 stage 78 (20.6 %) 38 (48.7 %) 40 (51.3 %)  
 3 stage 54 (14.2 %) 32 (59.3 %) 22 (40.7 %)  
 4 stage 173 (45.6 %) 115 (66.5 %) 58 (33.5 %)